Global Oocyte Cryopreservation Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Oocyte Cryopreservation market size will reach 138.04 Million USD in 2025 and is projected to reach 393.68 Million USD by 2032, with a CAGR of 16.15% (2025-2032). Notably, the China Oocyte Cryopreservation market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Oocyte cryopreservation, commonly known as egg freezing, is a medical procedure that involves the collection, freezing, and long-term storage of a woman＇s mature eggs (oocytes) for future use. This technology has gained prominence as a method for preserving a woman＇s fertility, particularly when she wants to delay childbearing for personal, medical, or professional reasons. Oocyte cryopreservation allows women to freeze their eggs at a point when they are younger and have a better chance of successful fertilization in the future. The frozen eggs can be thawed, fertilized with sperm, and implanted into the uterus through in vitro fertilization (IVF) at a later time, offering an option for family planning and addressing age-related fertility concerns.
The major global suppliers of Oocyte Cryopreservation include Anova Fertility, CCRM IVF, Chill, CREATE Fertility, HRC Fertility, Extend Fertility, IVF Australia, Kindbody, London Women’s Clinic, Manchester Fertility, Mayo Clinic, Melbourne IVF, Pacific Fertility Center-Los Angeles, Monash IVF, PIVET, Prelude Fertility, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Oocyte Cryopreservation. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Oocyte Cryopreservation market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Oocyte Cryopreservation market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Oocyte Cryopreservation industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Oocyte Cryopreservation Include:
Anova Fertility
CCRM IVF
Chill
CREATE Fertility
HRC Fertility
Extend Fertility
IVF Australia
Kindbody
London Women’s Clinic
Manchester Fertility
Mayo Clinic
Melbourne IVF
Pacific Fertility Center-Los Angeles
Monash IVF
PIVET
Prelude Fertility
Oocyte Cryopreservation Product Segment Include:
Oral Drug
External Drug
Oocyte Cryopreservation Product Application Include:
25-30 Year Old Female
30-35 Year Old Female
35-40 Year Old Female
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Oocyte Cryopreservation Industry PESTEL Analysis
Chapter 3: Global Oocyte Cryopreservation Industry Porter's Five Forces Analysis
Chapter 4: Global Oocyte Cryopreservation Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Oocyte Cryopreservation Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Oocyte Cryopreservation Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Oocyte Cryopreservation Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Oocyte Cryopreservation market size will reach 138.04 Million USD in 2025 and is projected to reach 393.68 Million USD by 2032, with a CAGR of 16.15% (2025-2032). Notably, the China Oocyte Cryopreservation market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Oocyte cryopreservation, commonly known as egg freezing, is a medical procedure that involves the collection, freezing, and long-term storage of a woman＇s mature eggs (oocytes) for future use. This technology has gained prominence as a method for preserving a woman＇s fertility, particularly when she wants to delay childbearing for personal, medical, or professional reasons. Oocyte cryopreservation allows women to freeze their eggs at a point when they are younger and have a better chance of successful fertilization in the future. The frozen eggs can be thawed, fertilized with sperm, and implanted into the uterus through in vitro fertilization (IVF) at a later time, offering an option for family planning and addressing age-related fertility concerns.
The major global suppliers of Oocyte Cryopreservation include Anova Fertility, CCRM IVF, Chill, CREATE Fertility, HRC Fertility, Extend Fertility, IVF Australia, Kindbody, London Women’s Clinic, Manchester Fertility, Mayo Clinic, Melbourne IVF, Pacific Fertility Center-Los Angeles, Monash IVF, PIVET, Prelude Fertility, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Oocyte Cryopreservation. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Oocyte Cryopreservation market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Oocyte Cryopreservation market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Oocyte Cryopreservation industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Oocyte Cryopreservation Include:
Anova Fertility
CCRM IVF
Chill
CREATE Fertility
HRC Fertility
Extend Fertility
IVF Australia
Kindbody
London Women’s Clinic
Manchester Fertility
Mayo Clinic
Melbourne IVF
Pacific Fertility Center-Los Angeles
Monash IVF
PIVET
Prelude Fertility
Oocyte Cryopreservation Product Segment Include:
Oral Drug
External Drug
Oocyte Cryopreservation Product Application Include:
25-30 Year Old Female
30-35 Year Old Female
35-40 Year Old Female
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Oocyte Cryopreservation Industry PESTEL Analysis
Chapter 3: Global Oocyte Cryopreservation Industry Porter's Five Forces Analysis
Chapter 4: Global Oocyte Cryopreservation Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Oocyte Cryopreservation Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Oocyte Cryopreservation Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Oocyte Cryopreservation Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Oocyte Cryopreservation Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Oocyte Cryopreservation Product by Type
- 1.2.1 Oral Drug
- 1.2.2 External Drug
- 1.3 Oocyte Cryopreservation Product by Application
- 1.3.1 25-30 Year Old Female
- 1.3.2 30-35 Year Old Female
- 1.3.3 35-40 Year Old Female
- 1.3.4 Others
- 1.4 Global Oocyte Cryopreservation Market Size Analysis (2020-2032)
- 1.5 Oocyte Cryopreservation Market Development Status and Trends
- 1.5.1 Oocyte Cryopreservation Industry Development Status Analysis
- 1.5.2 Oocyte Cryopreservation Industry Development Trends Analysis
- 2 Oocyte Cryopreservation Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Oocyte Cryopreservation Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Oocyte Cryopreservation Market Analysis by Country
- 4.1 Global Oocyte Cryopreservation Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Oocyte Cryopreservation Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Oocyte Cryopreservation Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Oocyte Cryopreservation Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Oocyte Cryopreservation Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Oocyte Cryopreservation Market Revenue and Growth Rate (2020-2032)
- 4.5 China Oocyte Cryopreservation Market Revenue and Growth Rate (2020-2032)
- 4.6 France Oocyte Cryopreservation Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Oocyte Cryopreservation Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Oocyte Cryopreservation Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Oocyte Cryopreservation Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Oocyte Cryopreservation Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Oocyte Cryopreservation Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Oocyte Cryopreservation Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Oocyte Cryopreservation Market Revenue and Growth Rate (2020-2032)
- 4.14 India Oocyte Cryopreservation Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Oocyte Cryopreservation Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Oocyte Cryopreservation Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Oocyte Cryopreservation Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Oocyte Cryopreservation Market Revenue by Key Suppliers (2021-2025)
- 5.2 Oocyte Cryopreservation Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Oocyte Cryopreservation Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Oocyte Cryopreservation Market Analysis by Type
- 6.1 Global Oocyte Cryopreservation Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Oocyte Cryopreservation Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Anova Fertility
- 7.1.1 Anova Fertility Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Anova Fertility Oocyte Cryopreservation Product Portfolio
- 7.1.3 Anova Fertility Oocyte Cryopreservation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 CCRM IVF
- 7.2.1 CCRM IVF Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 CCRM IVF Oocyte Cryopreservation Product Portfolio
- 7.2.3 CCRM IVF Oocyte Cryopreservation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Chill
- 7.3.1 Chill Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Chill Oocyte Cryopreservation Product Portfolio
- 7.3.3 Chill Oocyte Cryopreservation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 CREATE Fertility
- 7.4.1 CREATE Fertility Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 CREATE Fertility Oocyte Cryopreservation Product Portfolio
- 7.4.3 CREATE Fertility Oocyte Cryopreservation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 HRC Fertility
- 7.5.1 HRC Fertility Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 HRC Fertility Oocyte Cryopreservation Product Portfolio
- 7.5.3 HRC Fertility Oocyte Cryopreservation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Extend Fertility
- 7.6.1 Extend Fertility Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Extend Fertility Oocyte Cryopreservation Product Portfolio
- 7.6.3 Extend Fertility Oocyte Cryopreservation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 IVF Australia
- 7.7.1 IVF Australia Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 IVF Australia Oocyte Cryopreservation Product Portfolio
- 7.7.3 IVF Australia Oocyte Cryopreservation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Kindbody
- 7.8.1 Kindbody Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Kindbody Oocyte Cryopreservation Product Portfolio
- 7.8.3 Kindbody Oocyte Cryopreservation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 London Women’s Clinic
- 7.9.1 London Women’s Clinic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 London Women’s Clinic Oocyte Cryopreservation Product Portfolio
- 7.9.3 London Women’s Clinic Oocyte Cryopreservation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Manchester Fertility
- 7.10.1 Manchester Fertility Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Manchester Fertility Oocyte Cryopreservation Product Portfolio
- 7.10.3 Manchester Fertility Oocyte Cryopreservation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 Mayo Clinic
- 7.11.1 Mayo Clinic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Mayo Clinic Oocyte Cryopreservation Product Portfolio
- 7.11.3 Mayo Clinic Oocyte Cryopreservation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 Melbourne IVF
- 7.12.1 Melbourne IVF Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 Melbourne IVF Oocyte Cryopreservation Product Portfolio
- 7.12.3 Melbourne IVF Oocyte Cryopreservation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.13 Pacific Fertility Center-Los Angeles
- 7.13.1 Pacific Fertility Center-Los Angeles Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 Pacific Fertility Center-Los Angeles Oocyte Cryopreservation Product Portfolio
- 7.13.3 Pacific Fertility Center-Los Angeles Oocyte Cryopreservation Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.14 Monash IVF
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
